Peripheral vascular diseases, such as peripheral arterial disease (PAD) and deep vein thrombosis (DVT), significantly affect patients' health and quality of life. In Romania, these conditions are responsible for a significant number of hospitalizations and complications that can lead to disability or even death.
Dr. Rodica Niculescu
Modern minimally invasive technologies, such as the Jetstream and AngioJet systems, have been adopted relatively recently by interventional cardiology specialists to improve patient treatment and outcomes. These interventions offer solutions to reduce risks and improve recovery, giving patients the chance for an active life.
Peripheral artery disease (PAD) is a condition in which the arteries that supply blood to the limbs become narrowed or blocked due to atherosclerosis, leading to symptoms such as pain, claudication and, in severe cases, ulceration or gangrene. Deep vein thrombosis (DVT), on the other hand, is a condition where a blood clot forms in a deep vein, usually in the lower limbs, which can lead to serious complications such as pulmonary embolism.
In the past, treatments for BAP and DVT involved invasive surgical procedures with long recovery times and significant risks of complications. Currently, advances in medical technology allow the application of minimally invasive treatments, which offer considerable benefits in terms of safety and efficacy. Among these technologies, the Jetstream and AngioJet systems are popular for their ability to effectively treat arterial obstructions and venous thromboses.
In certain cases, the combination of minimally invasive technologies and traditional surgical techniques may be necessary to achieve the desired results. Hybrid interventions involve the simultaneous or sequential use of different approaches to treat complex conditions.
On Thursday, from 1:00 p.m., Dr. Rodica Niculescu, primary cardiology physician, head of the Department of Interventional Cardiology, SANADOR Clinical Hospital, will explain on Adevăru Live the evolution of minimally invasive interventions in the treatment of deep vein thrombosis.
